One Week Parathyroid Hormone-related Protein (PTHrP) IV Dose Escalation Study

NCT00580788 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

COMPLETED

Status

14

Enrollment

OTHER

Sponsor class

Conditions

Osteoporosis
Humoral Hypercalcemia of Malignancy
Hyperparathyroidism

Interventions

DRUG: PTHrP (1-36)

Sponsor

University of Pittsburgh

Collaborators

[object Object]